Krakow, Poland

NZOZ Centrum Medyczne Promimed

Rheumatoid Arthritis

Arthritis

Ulcer

Colitis

Ulcerative Colitis

ASP015K

Etrolizumab

Methotrexate

Adalimumab

Filgotinib

Roche

Astellas

Galapagos

condition

allSponsorName

Gilead Sciences

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The primary objective of this study is to evaluate the long-term safety and tolerability of filgotinib in participants who have completed one of the parent studies of filgotinib in rheumatoid arthritis (RA).

Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults with Rheumatoid Arthritis

NZOZ Centrum Medyczne Promimed | Krakow, Poland

Site insights

Work at this site?

Active trials

Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults with Rheumatoid Arthritis (FINCH 4)

Trial sponsors